Vaccine developer AstraZeneca buys US drug company for 39 billion dollars

Belfast Telegraph

12 Dec 2020 0 shares 1 views

Belfast Telegraph

Published 12 Dec 2020

Pharmaceutical giant AstraZeneca has said it is buying a US drug company in a deal worth 39 billion US dollars (£29 billion).

Time To End Patent Monopolies – OpEd

Eurasia Review 24 Dec 2020

For several years the opioid crisis has been recognized as a major national catastrophe. Millions of people have become addicted to..

British pharmaceuticals group AstraZeneca, which is finalising a vaccine against Covid-19, said Saturday it was buying US biotech..

Mid-Day 12 Dec 2020

LONDON (AP) — Pharmaceutical company AstraZeneca says it is buying U.S. drug developer Alexion in a deal worth $39..

SeattlePI.com 12 Dec 2020